Framingham Risk Score
Estimates 10-year coronary heart disease risk in men aged 30–74 without CHD — Wilson 1998 categorical points (total-cholesterol version for men).
Score interpretation
Points ≤ 2: 10-year CHD risk 2–4 % (Wilson 1998, men).
→ Lifestyle advice; reassess periodically.
Points 3–5: 10-year CHD risk 5–8 %.
→ Lifestyle modification; address modifiable risk factors.
Points 6–8: 10-year CHD risk 10–16 %.
→ Consider statin therapy; optimise blood pressure and lipids.
Points ≥ 9: 10-year CHD risk 20 % or more.
→ Statin therapy and blood-pressure control; consider specialist review if symptomatic.
Interpretation bands for the Framingham. Apply clinical judgement and local guidance.
References
- Wilson PW et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998.
Related
Curated clinical cross-links plus same-class fallbacks.
- ACC/AHA Pooled Cohort Equations — ASCVD Risk · Cardiovascular Risk
- PREVENT Cardiovascular Risk Calculator (AHA/ACC 2023) · Cardiovascular Risk
- Reynolds Risk Score for Women · Cardiovascular Risk
- SCORE2 — 10-Year CVD Risk (Age 40–69) · Cardiovascular Risk
- SCORE2-OP — 5/10-Year CVD Risk (Age ≥ 70) · Cardiovascular Risk
- SCORE2-Diabetes 10-Year CVD Risk in Type 2 Diabetes · Cardiovascular Risk
- Atorvastatin (CKD Cardiovascular Risk) · Cardiovascular Risk in CKD
- Icosapent Ethyl (Omega-3 — Cardiovascular Risk Reduction) · Omega-3 Fatty Acid (Purified EPA — Eicosapentaenoic Acid Ethyl Ester)
- Fluvastatin · HMG-CoA reductase inhibitor (statin)
- Pravastatin sodium · HMG-CoA reductase inhibitor (hydrophilic statin)
- Simvastatin with ezetimibe · HMG-CoA reductase inhibitor + cholesterol absorption inhibitor
- Bempedoic acid with ezetimibe · ATP-citrate lyase inhibitor + cholesterol absorption inhibitor
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.